SL

Siren LLC Portfolio holdings

AUM $3.35B
1-Year Est. Return 103.36%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+103.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.35B
AUM Growth
+$796M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
141
New
Increased
Reduced
Closed

Top Buys

1
+$59.1M
2
+$58.7M
3
+$36.6M
4
DBVT
DBV Technologies
DBVT
+$29M
5
MLYS icon
Mineralys Therapeutics
MLYS
+$28.1M

Top Sells

1
+$57.3M
2
+$56M
3
+$45.8M
4
SLNO icon
Soleno Therapeutics
SLNO
+$31.6M
5
DYN icon
Dyne Therapeutics
DYN
+$23.2M

Sector Composition

1 Healthcare 93.02%
2 Technology 3.72%
3 Communication Services 1.9%
4 Real Estate 0.59%
5 Consumer Discretionary 0.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARM icon
101
Arm
ARM
$128B
$2.35M 0.07%
+21,500
BEKE icon
102
KE Holdings
BEKE
$18.3B
$2.29M 0.07%
145,000
TIL icon
103
Instil Bio
TIL
$58M
$2.24M 0.07%
203,933
PANW icon
104
Palo Alto Networks
PANW
$133B
$2.11M 0.06%
11,450
-2,000
CRWV
105
CoreWeave Inc
CRWV
$39.3B
$1.97M 0.06%
27,500
+3,500
IREN icon
106
Iris Energy
IREN
$13.3B
$1.63M 0.05%
43,100
+23,100
VRNS icon
107
Varonis Systems
VRNS
$2.8B
$1.23M 0.04%
+37,500
PRMB
108
Primo Brands
PRMB
$7.95B
$1.23M 0.04%
75,000
GBIO
109
DELISTED
Generation Bio
GBIO
$1.14M 0.03%
201,419
-95,473
FIG
110
Figma
FIG
$15.8B
$934K 0.03%
25,000
+10,000
TSLA icon
111
Tesla
TSLA
$1.52T
$675K 0.02%
1,500
CRBU icon
112
Caribou Biosciences
CRBU
$160M
$168K 0.01%
105,347
CYCN icon
113
Cyclerion Therapeutics
CYCN
$5.29M
$147K ﹤0.01%
115,603
-552
NIQ
114
NIQ Global Intelligence PLC
NIQ
$3.89B
– –
-95,000
CCC
115
CCC Intelligent Solutions
CCC
$3.74B
– –
-50,000
CFLT icon
116
Confluent
CFLT
$11B
– –
-37,500
CMG icon
117
Chipotle Mexican Grill
CMG
$48.3B
– –
-47,500
ELDN icon
118
Eledon Pharmaceuticals
ELDN
$209M
– –
-2,072,767
ESTC icon
119
Elastic
ESTC
$5.52B
– –
-12,500
HUBS icon
120
HubSpot
HUBS
$15.4B
– –
-4,000
IRWD icon
121
Ironwood Pharmaceuticals
IRWD
$590M
– –
-110,532
KDP icon
122
Keurig Dr Pepper
KDP
$38.1B
– –
-77,050
KVUE icon
123
Kenvue
KVUE
$35B
– –
-25,000
NAMS icon
124
NewAmsterdam Pharma
NAMS
$3.47B
– –
-765,705
PCOR icon
125
Procore
PCOR
$8.9B
– –
-10,000
2 3 4
5
6